Aboriginal and Prisoner HCV Drug Coverage for HOLKIRA PAK™

On September 11th we were notified that AbbVie's new interferon-free hepatitis C treatment for genotype 1, HOLKIRA PAK™ (ombitasvir, paritaprevir, ritonovir and dasabuvir [±ribavirin]), is now formally listed by the Non-Insured Health Benefit Program (NIHB) and Correctional Services Canada (CSC). Both have listed HOLKIRA PAK™ in accordance with the Common Drug Review’s recommendations: liver fibrosis stage of ≥2, and treatment should be initiated by physic